Logo image of HCAT

HEALTH CATALYST INC (HCAT) Stock Price, Quote, News and Overview

NASDAQ:HCAT - Nasdaq - US42225T1079 - Common Stock - Currency: USD

3.795  -0.19 (-4.65%)

After market: 3.795 0 (0%)

HCAT Quote, Performance and Key Statistics

HEALTH CATALYST INC

NASDAQ:HCAT (6/13/2025, 4:30:01 PM)

After market: 3.795 0 (0%)

3.795

-0.19 (-4.65%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Technology
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Technology
Statistics
52 Week High9.24
52 Week Low3.49
Market Cap264.13M
Shares69.60M
Float66.68M
Yearly DividendN/A
Dividend YieldN/A
PE15.81
Fwd PE9.09
Earnings (Next)08-05 2025-08-05/amc
IPO07-25 2019-07-25


HCAT short term performance overview.The bars show the price performance of HCAT in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -10 -20 -30 -40 -50

HCAT long term performance overview.The bars show the price performance of HCAT in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60

The current stock price of HCAT is 3.795 USD. In the past month the price decreased by -7.54%. In the past year, price decreased by -41.25%.

HEALTH CATALYST INC / HCAT Daily stock chart

HCAT Competitors/Peers

The largest stocks on the US markets in the "Health Care Technology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
VEEV VEEVA SYSTEMS INC-CLASS A 39.91 46.04B
DOCS DOXIMITY INC-CLASS A 39.66 10.50B
WAY WAYSTAR HOLDING CORP 49.28 6.74B
CERT CERTARA INC 22.47 1.79B
SDGR SCHRODINGER INC N/A 1.57B
GDRX GOODRX HOLDINGS INC-CLASS A 12.85 1.56B
PHR PHREESIA INC N/A 1.55B
TDOC TELADOC HEALTH INC N/A 1.20B
LFMDP LIFEMD INC - LFMD 8 7/8 PERP N/A 1.08B
EVH EVOLENT HEALTH INC - A 21.76 970.90M
HSTM HEALTHSTREAM INC 43.25 831.94M
CCLDO CARECLOUD INC - CCLD 8 3/4 PERP N/A 793.50M

About HCAT

Company Profile

HCAT logo image Health Catalyst, Inc. engages in the provision of data and analytics technology and services to healthcare organizations. The company is headquartered in South Jordan, Utah. The company went IPO on 2019-07-25. The firm's solution comprises its cloud-based data platform, applications, and expertise. Its segments include Technology and Professional Services. The Technology segment includes its data platform, analytics applications and support services and earns primarily from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees. The Professional Services segment is generally a combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver capabilities to its clients to fully configure and utilize the benefits of its technology offerings. Its clients, which are primarily healthcare providers, use its Solution to manage their data, derive analytical insights to operate their organization, and produce measurable clinical, financial, and operational improvements.

Company Info

HEALTH CATALYST INC

10897 South River Front Parkway, #300

South Jordan UTAH 84121 US

CEO: Daniel Burton

Employees: 1500

HCAT Company Website

HCAT Investor Relations

Phone: 18017086800

HEALTH CATALYST INC / HCAT FAQ

What is the stock price of HEALTH CATALYST INC today?

The current stock price of HCAT is 3.795 USD. The price decreased by -4.65% in the last trading session.


What is the ticker symbol for HEALTH CATALYST INC stock?

The exchange symbol of HEALTH CATALYST INC is HCAT and it is listed on the Nasdaq exchange.


On which exchange is HCAT stock listed?

HCAT stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for HEALTH CATALYST INC stock?

19 analysts have analysed HCAT and the average price target is 8.16 USD. This implies a price increase of 115.02% is expected in the next year compared to the current price of 3.795. Check the HEALTH CATALYST INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is HEALTH CATALYST INC worth?

HEALTH CATALYST INC (HCAT) has a market capitalization of 264.13M USD. This makes HCAT a Micro Cap stock.


How many employees does HEALTH CATALYST INC have?

HEALTH CATALYST INC (HCAT) currently has 1500 employees.


What are the support and resistance levels for HEALTH CATALYST INC (HCAT) stock?

HEALTH CATALYST INC (HCAT) has a support level at 3.58 and a resistance level at 3.89. Check the full technical report for a detailed analysis of HCAT support and resistance levels.


Is HEALTH CATALYST INC (HCAT) expected to grow?

The Revenue of HEALTH CATALYST INC (HCAT) is expected to grow by 9.06% in the next year. Check the estimates tab for more information on the HCAT EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy HEALTH CATALYST INC (HCAT) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does HEALTH CATALYST INC (HCAT) stock pay dividends?

HCAT does not pay a dividend.


When does HEALTH CATALYST INC (HCAT) report earnings?

HEALTH CATALYST INC (HCAT) will report earnings on 2025-08-05, after the market close.


What is the Price/Earnings (PE) ratio of HEALTH CATALYST INC (HCAT)?

The PE ratio for HEALTH CATALYST INC (HCAT) is 15.81. This is based on the reported non-GAAP earnings per share of 0.24 and the current share price of 3.795 USD. Check the full fundamental report for a full analysis of the valuation metrics for HCAT.


What is the Short Interest ratio of HEALTH CATALYST INC (HCAT) stock?

The outstanding short interest for HEALTH CATALYST INC (HCAT) is 4.81% of its float. Check the ownership tab for more information on the HCAT short interest.


HCAT Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

HCAT Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to HCAT. Both the profitability and financial health of HCAT have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

HCAT Financial Highlights

Over the last trailing twelve months HCAT reported a non-GAAP Earnings per Share(EPS) of 0.24. The EPS increased by 60% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -8.15%
ROE -19.28%
Debt/Equity 0.4
Chartmill High Growth Momentum
EPS Q2Q%-80%
Sales Q2Q%6.28%
EPS 1Y (TTM)60%
Revenue 1Y (TTM)4.88%

HCAT Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 80% to HCAT. The Buy consensus is the average rating of analysts ratings from 19 analysts.

For the next year, analysts expect an EPS growth of 7.17% and a revenue growth 9.06% for HCAT


Ownership
Inst Owners89.34%
Ins Owners2.43%
Short Float %4.81%
Short Ratio5.64
Analysts
Analysts80
Price Target8.16 (115.02%)
EPS Next Y7.17%
Revenue Next Year9.06%